126 related articles for article (PubMed ID: 9500559)
1. Decreased activity of arachidonate 12-lipoxygenase in platelets of Japanese patients with non-insulin-dependent diabetes mellitus.
Tohjima T; Honda N; Mochizuki K; Kinoshita J; Watanabe K; Arisaka T; Kawamori R; Nakamura M; Kurahashi Y; Yoshimoto T; Yamamoto S
Metabolism; 1998 Mar; 47(3):257-63. PubMed ID: 9500559
[TBL] [Abstract][Full Text] [Related]
2. Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM.
Yki-Järvinen H; Daniels MC; Virkamäki A; Mäkimattila S; DeFronzo RA; McClain D
Diabetes; 1996 Mar; 45(3):302-7. PubMed ID: 8593934
[TBL] [Abstract][Full Text] [Related]
3. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
[TBL] [Abstract][Full Text] [Related]
4. Catalytic amounts of fructose may improve glucose tolerance in subjects with uncontrolled non-insulin-dependent diabetes.
Vaisman N; Niv E; Izkhakov Y
Clin Nutr; 2006 Aug; 25(4):617-21. PubMed ID: 16403592
[TBL] [Abstract][Full Text] [Related]
5. Decreased messenger RNA of arachidonate 12-lipoxygenase in platelets of patients with myeloproliferative disorders.
Matsuda S; Murakami J; Yamamoto Y; Konishi Y; Yokoyama C; Yoshimoto T; Yamamoto S; Mimura Y; Okuma M
Biochim Biophys Acta; 1993 Jan; 1180(3):243-9. PubMed ID: 8422429
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the presence of phospholipid hydroperoxide glutathione peroxidase in human platelets: implications for its involvement in the regulatory network of the 12-lipoxygenase pathway of arachidonic acid metabolism.
Sutherland M; Shankaranarayanan P; Schewe T; Nigam S
Biochem J; 2001 Jan; 353(Pt 1):91-100. PubMed ID: 11115402
[TBL] [Abstract][Full Text] [Related]
7. Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of arachidonic acid in human platelets.
Dragan YP; Ellis EF
Biochem Pharmacol; 1990 Jan; 39(1):27-32. PubMed ID: 2105095
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
Chon S; Lee YJ; Fraterrigo G; Pozzilli P; Choi MC; Kwon MK; Chin SO; Rhee SY; Oh S; Kim YS; Woo JT
Diabetes Technol Ther; 2013 Jun; 15(6):455-60. PubMed ID: 23617251
[TBL] [Abstract][Full Text] [Related]
9. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
[TBL] [Abstract][Full Text] [Related]
10. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
11. Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients.
Rabini RA; Staffolani R; Fumelli P; Mutus B; Curatola G; Mazzanti L
Diabetologia; 1998 Jan; 41(1):101-4. PubMed ID: 9498637
[TBL] [Abstract][Full Text] [Related]
12. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
[TBL] [Abstract][Full Text] [Related]
13. Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations.
Gotoh M; Li C; Yatoh M; Iguchi A; Hirooka Y
Endocr Regul; 2005 Dec; 39(4):119-25. PubMed ID: 16552989
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-dependent soluble guanylate cyclase activity is decreased in platelets from male NIDDM patients.
Michimata T; Murakami M; Iriuchijima T
Life Sci; 1996; 59(17):1463-71. PubMed ID: 8890925
[TBL] [Abstract][Full Text] [Related]
15. Surface expression of fatty acid translocase (FAT/CD36) on platelets in myeloproliferative disorders and non-insulin dependent diabetes mellitus: effect on arachidonic acid uptake.
Salah-Uddin H; Gordon MJ; Ford I; Tandon NN; Greaves M; Duttaroy AK
Mol Cell Biochem; 2002 Oct; 239(1-2):203-11. PubMed ID: 12479587
[TBL] [Abstract][Full Text] [Related]
16. Patterns of glucose and lipid abnormalities in black NIDDM subjects.
Chaiken RL; Banerji MA; Pasmantier R; Huey H; Hirsch S; Lebovitz HE
Diabetes Care; 1991 Nov; 14(11):1036-42. PubMed ID: 1797484
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
[TBL] [Abstract][Full Text] [Related]
18. Activation of human platelet protein kinase C-beta 2 in vivo in response to acute hyperglycemia.
Pirags V; Assert R; Haupt K; Schatz H; Pfeiffer A
Exp Clin Endocrinol Diabetes; 1996; 104(6):431-40. PubMed ID: 9021343
[TBL] [Abstract][Full Text] [Related]
19. Conditions for the formation of the oxo derivatives of arachidonic acid from platelet 12-lipoxygenase and soybean 15-lipoxygenase.
Fruteau de Laclos B; Borgeat P
Biochim Biophys Acta; 1988 Feb; 958(3):424-33. PubMed ID: 3124882
[TBL] [Abstract][Full Text] [Related]
20. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
